Related Experiment Video
Updated: Apr 8, 2026

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
Published on: May 24, 2016
Contemporary perspective on endogenous myocardial regeneration
Dejan Milasinovic1, Werner Mohl1
1Dejan Milasinovic, Department of Cardiology, Clinical Centre of Serbia, 11000 Belgrade, Serbia.
Insights
The adult heart has limited self-repair capabilities. This review explores endogenous myocardial regeneration mechanisms and clinical evidence, suggesting developmental pathways could revolutionize heart failure treatment.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Cardiac Physiology
Background:
- The adult heart's regenerative capacity is insufficient to repair significant damage.
- Understanding endogenous repair mechanisms is crucial for treating heart failure.
- Existing limitations hinder complete myocardial recovery after injury.
Purpose of the Study:
- To review mechanisms and origins of endogenous myocardial regeneration.
- To analyze the role of clinical conditions in initiating regeneration.
- To evaluate clinical studies on stimulating regeneration in failing human hearts.
Main Methods:
- Examined experimental data on replicating cardiac myocytes and progenitor cells (e.g., c-kit+ cells).
- Described clinical settings like myocardial ischemia as regenerative pathway initiators.
- Analyzed clinical trials investigating endogenous regeneration in human heart failure.
Main Results:
- Identified cardiac progenitor cells and their role in myocyte replication.
- Demonstrated that ischemia can activate endogenous regenerative pathways.
- Clinical studies show potential for initiating regeneration in failing hearts.
Conclusions:
- Endogenous regenerative pathways offer a new therapeutic paradigm for heart failure.
- Reinitiating developmental pathways (embryonic recall) may enable tissue regeneration.
- This approach could lead to a paradigm shift in treating dysfunctional myocardium.
Abstract:
Considering the complex nature of the adult heart, it is no wonder that innate regenerative processes, while maintaining adequate cardiac function, fall short in myocardial jeopardy. In spite of these enchaining limitations, cardiac rejuvenation occurs as well as restricted regeneration. In this review, the background as well as potential mechanisms of endogenous myocardial regeneration are summarized. We present and analyze the available evidence in three subsequent steps. First, we examine the experimental research data that provide insights into the mechanisms and origins of the replicating cardiac myocytes, including cell populations referred to as cardiac progenitor cells (i.e., c-kit+ cells). Second, we describe the role of clinical settings such as acute or chronic myocardial ischemia, as initiators of pathways of endogenous myocardial regeneration. Third, the hitherto conducted clinical studies that examined different approaches of initiating endogenous myocardial regeneration in failing human hearts are analyzed. In conclusion, we present the evidence in support of the notion that regaining cardiac function beyond cellular replacement of dysfunctional myocardium via initiation of innate regenerative pathways could create a new perspective and a paradigm change in heart failure therapeutics. Reinitiating cardiac morphogenesis by reintroducing developmental pathways in the adult failing heart might provide a feasible way of tissue regeneration. Based on our hypothesis "embryonic recall", we present first supporting evidence on regenerative impulses in the myocardium, as induced by developmental processes.

